Intrinsiqq

InterCure Ltd. (INCR) Financials

All currency values in ILS millions unless otherwise noted

Scroll

Income Statement
DEC 2025
DEC 2024
DEC 2023
DEC 2022
DEC 2021
Revenues
RevenueILS 270ILS 239ILS 356ILS 389ILS 220
Cost of RevenueILS 237ILS 209ILS 250ILS 234ILS 129
Gross ProfitILS 33ILS 30ILS 105ILS 155ILS 91
Total Operating ExpensesILS 26ILS 75ILS 68ILS 114ILS 58
Operating IncomeILS 7-ILS 45ILS 38ILS 41ILS 33
Non-Operating
Net Interest Expense-ILS 20-ILS 21-ILS 24-ILS 15-ILS 5
Income Tax Expense-ILS 7-ILS 15ILS 2ILS 0ILS 11
Net Income
Net Income-ILS 37-ILS 73-ILS 64ILS 44ILS 7
Per Share Data
Revenue Per ShareILS 5.89ILS 5.21ILS 7.80ILS 8.57ILS 5.71
EPS (Basic)-ILS 0.80-ILS 1.59-ILS 1.36ILS 0.99ILS 0.12
EPS (Diluted)-ILS 0.80-ILS 1.59-ILS 1.36ILS 0.99ILS 0.10
Shares Outstanding45.9M45.9M45.6M45.4M38.5M
Dividends Per ShareILS 0.00ILS 0.00ILS 0.00ILS 0.00ILS 0.00

InterCure (INCR) financials: revenue, profit and margins

InterCure (INCR) generated about ILS 270 million in revenue and -ILS 37 million in net income (a -13.6% net margin) over the trailing twelve months, growing at roughly 5.3% a year. Figures are from company filings; this is analysis, not investment advice.

Frequently asked

What is InterCure's (INCR) revenue?+

InterCure generated about ILS 270 million in revenue over the trailing twelve months. Revenue has grown at roughly 5.3% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is InterCure profitable?+

InterCure reported about -ILS 37 million in net loss over the trailing twelve months, a net margin of roughly -13.6%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

What are InterCure's profit margins?+

InterCure runs a gross margin of about 12.3%, an operating margin of about 2.5%, a net margin of about -13.6%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.

How fast is InterCure growing?+

InterCure's revenue has compounded at roughly 5.3% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside INCR's margins and free cash flow. This is analysis from company filings, not investment advice.

How the market compares: How many US companies are profitable

Related stocks: Drug Manufacturers - Specialty & Generic

Spot a number that looks wrong?

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.